Ownership Filing for Eiry Roberts

This filing details the ownership of NEUROCRINE BIOSCIENCES INC (NBIX) by Eiry Roberts, the Chief Medical Officer. As of September 28, 2026, Roberts directly owns 51,331 shares of common stock. The filing also discloses various stock options and restricted stock units (RSUs) granted to Roberts, with details on their exercise prices, expiration dates, and vesting schedules. Notably, some options have exercise prices ranging from $79.02 to $136.69, and RSUs are set to vest through February 2029. A portion of the shares are held under a joint trust agreement where Dr. Roberts has voting and investment power. The filing indicates a total of 17 derivative holdings, including non-qualified stock options and incentive stock options, along with 5 non-derivative holdings classified as restricted stock units.